Pimavanserin 34 milligrams (MG) [Nuplazid]
2019-001722-10
Phase 2 small_molecule terminated
Quick answer
Pimavanserin 34 milligrams (MG) [Nuplazid] for Schizophrenia is a Phase 2 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Schizophrenia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated